ALLIED HEALTHCARE PRODUCTS, INC.: 10-Q filed 2021-02-16

Name: ALLIED HEALTHCARE PRODUCTS, INC.: 10-Q filed 2021-02-16
Creator: ALLIED HEALTHCARE PRODUCTS, INC.

What ALLIED HEALTHCARE PRODUCTS, INC. reported in its quarterly report filed 2021-02-16 (fiscal Q2 2021): 36 published measures, 106 facts as tagged in accession 0001104659-21-023411.

This filing

Form: 10-Q (quarterly report)
Filed: 2021-02-16
Fiscal period: fiscal Q2 2021
Accession: 0001104659-21-023411 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ALLIED HEALTHCARE PRODUCTS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-12-31	20,040,142	USD
At 2020-06-30	19,672,359	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-12-31	9,429,794	USD
At 2020-09-30	8,725,815	USD
At 2020-06-30	8,878,667	USD
At 2019-12-31	9,746,102	USD
At 2019-09-30	11,277,022	USD
At 2019-06-30	11,890,352	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2020-12-31	1,128,511	USD
At 2020-06-30	2,600,083	USD
At 2019-12-31	351,583	USD
At 2019-06-30	195,454	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	700,478	USD	92
2020-07-01 to 2020-12-31	547,097	USD	184
2019-10-01 to 2019-12-31	-1,531,484	USD	92
2019-07-01 to 2019-12-31	-2,145,607	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	-3,413,749	USD	184
2019-07-01 to 2019-12-31	-801,274	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	167,163	USD	184
2019-07-01 to 2019-12-31	28,387	USD	184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	11,103,528	USD	92
2020-07-01 to 2020-12-31	21,293,076	USD	184
2019-10-01 to 2019-12-31	7,309,785	USD	92
2019-07-01 to 2019-12-31	15,285,422	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	2,109,340	USD	184
2019-07-01 to 2019-12-31	985,790	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	-167,163	USD	184
2019-07-01 to 2019-12-31	-28,387	USD	184

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	4,013,537	shares	92
2020-07-01 to 2020-12-31	4,013,537	shares	184
2019-10-01 to 2019-12-31	4,013,537	shares	92
2019-07-01 to 2019-12-31	4,013,537	shares	184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	4,024,952	shares	92
2020-07-01 to 2020-12-31	4,027,788	shares	184
2019-10-01 to 2019-12-31	4,013,537	shares	92
2019-07-01 to 2019-12-31	4,013,537	shares	184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	0.17	USD/shares	92
2020-07-01 to 2020-12-31	0.14	USD/shares	184
2019-10-01 to 2019-12-31	-0.38	USD/shares	92
2019-07-01 to 2019-12-31	-0.53	USD/shares	184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	0.17	USD/shares	92
2020-07-01 to 2020-12-31	0.14	USD/shares	184
2019-10-01 to 2019-12-31	-0.38	USD/shares	92
2019-07-01 to 2019-12-31	-0.53	USD/shares	184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2020-10-01 to 2020-12-31	USD	92
2020-07-01 to 2020-12-31	USD	184
2019-10-01 to 2019-12-31	USD	92
2019-07-01 to 2019-12-31	USD	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-12-31	3,986,031	USD
At 2020-06-30	4,139,693	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	4,030	USD	184
2019-07-01 to 2019-12-31	1,357	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	733,888	USD	92
2020-07-01 to 2020-12-31	598,601	USD	184
2019-10-01 to 2019-12-31	-1,512,455	USD	92
2019-07-01 to 2019-12-31	-2,119,847	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-12-31	15,398,080	USD
At 2020-06-30	14,874,573	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	33,452	USD	92
2020-07-01 to 2020-12-31	51,703	USD	184
2019-10-01 to 2019-12-31	19,037	USD	92
2019-07-01 to 2019-12-31	25,789	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-12-31	10,040,425	USD
At 2020-06-30	8,925,411	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2020-12-31	3,060,274	USD
At 2020-06-30	2,940,006	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2020-12-31	3,697,031	USD
At 2020-06-30	3,103,819	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2020-12-31	10,220,254	USD
At 2020-06-30	8,928,688	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	2,612,195	USD	92
2020-07-01 to 2020-12-31	4,486,006	USD	184
2019-10-01 to 2019-12-31	1,347,178	USD	92
2019-07-01 to 2019-12-31	2,606,873	USD	184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	1,878,307	USD	92
2020-07-01 to 2020-12-31	3,887,405	USD	184
2019-10-01 to 2019-12-31	2,859,633	USD	92
2019-07-01 to 2019-12-31	4,726,720	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-12-31	4,013,537	shares
At 2020-06-30	4,013,537	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2020-12-31	-18,139,319	USD
At 2020-06-30	-18,686,416	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2020-12-31	15,264	USD
At 2020-06-30	17,326	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2020-12-31	2,370,400	USD
At 2020-06-30	2,106,131	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	700,478	USD	92
2020-07-01 to 2020-12-31	547,097	USD	184
2019-10-01 to 2019-12-31	-1,531,484	USD	92
2019-07-01 to 2019-12-31	-2,145,607	USD	184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	320,825	USD	184
2019-07-01 to 2019-12-31	322,866	USD	184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	0	USD	92
2020-07-01 to 2020-12-31	0	USD	184
2019-10-01 to 2019-12-31	-13	USD	92
2019-07-01 to 2019-12-31	-23	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2020-10-01 to 2020-12-31	-33,410	USD	92
2020-07-01 to 2020-12-31	-51,504	USD	184
2019-10-01 to 2019-12-31	-19,029	USD	92
2019-07-01 to 2019-12-31	-25,760	USD	184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	609,609	USD	184
2019-07-01 to 2019-12-31	-235,519	USD	184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	1,291,566	USD	184
2019-07-01 to 2019-12-31	163,964	USD	184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-12-31	120,268	USD	184
2019-07-01 to 2019-12-31	425,083	USD	184

Inspect the source

Entity: ALLIED HEALTHCARE PRODUCTS, INC. / CIK 0000874710
Captured: 2026-09-22 19:32 UTC
SEC response SHA-256: f694204a453d7f425517aaaf1b9247d581a7c239a0c125906f119959cddf46dc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000874710.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))